🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 22 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/02/2023 44,01 45,84 43,35 45,71 +3,58% 5,66% 749.500
16/02/2023 42,50 44,97 42,30 44,13 +2,94% 6,28% 931.900
15/02/2023 43,05 43,27 42,45 42,87 -1,11% 1,90% 1.347.700
14/02/2023 43,61 44,36 42,62 43,35 -1,19% 3,99% 744.900
13/02/2023 43,70 45,17 42,32 43,87 +0,67% 6,52% 1.108.000
10/02/2023 44,37 44,90 43,56 43,58 -1,63% 3,02% 1.005.200
09/02/2023 44,03 44,68 43,45 44,30 +0,93% 2,79% 514.900
08/02/2023 44,98 44,98 43,82 43,89 -2,42% 2,58% 668.300
07/02/2023 44,89 45,10 43,38 44,98 +0,31% 3,83% 625.100
06/02/2023 45,00 45,63 44,62 44,84 -0,38% 2,24% 649.400
03/02/2023 44,00 45,19 43,47 45,01 +1,01% 3,91% 998.300
02/02/2023 43,24 44,86 42,82 44,56 +4,04% 4,72% 983.800
01/02/2023 42,40 43,26 40,83 42,83 +0,82% 5,73% 1.063.100
31/01/2023 41,22 42,57 40,94 42,48 +3,46% 3,95% 908.700
30/01/2023 43,08 43,39 40,98 41,06 -4,78% 5,59% 907.200
27/01/2023 43,31 44,03 43,05 43,12 -0,30% 2,26% 405.900
26/01/2023 43,07 43,49 42,45 43,25 +0,68% 2,41% 494.600
25/01/2023 43,21 43,66 42,77 42,96 -0,44% 2,06% 1.066.600
24/01/2023 42,23 43,56 41,68 43,15 +2,25% 4,45% 1.197.900
23/01/2023 41,88 42,26 40,26 42,20 +0,98% 4,78% 1.498.800
20/01/2023 42,41 42,41 41,11 41,79 -0,33% 3,07% 684.300
19/01/2023 42,61 43,19 41,89 41,93 -1,39% 3,05% 776.400
18/01/2023 42,97 43,61 41,98 42,52 -0,47% 3,79% 532.700
17/01/2023 42,89 43,00 41,93 42,72 +0,61% 2,49% 639.200
13/01/2023 42,68 43,58 41,89 42,46 -0,84% 3,96% 780.500
12/01/2023 41,03 42,91 40,18 42,82 +3,76% 6,65% 925.400
11/01/2023 43,27 43,27 41,20 41,27 -4,95% 4,78% 1.060.500
10/01/2023 42,24 43,65 42,24 43,42 +2,65% 3,34% 920.500
09/01/2023 43,48 43,50 42,22 42,30 -1,97% 2,94% 820.500
06/01/2023 42,65 43,40 41,86 43,15 +1,46% 3,61% 786.200